Puma Biotechnology, Inc. (PBYI)
10.90
+0.14
(+1.30%)
USD |
NASDAQ |
Oct 21, 16:00
10.92
+0.02
(+0.14%)
After-Hours: 20:00
Puma Biotechnology Net Income (Annual) : 31.11M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 31.11M |
| December 31, 2024 | 30.28M |
| December 31, 2023 | 21.59M |
| December 31, 2022 | 0.002M |
| December 31, 2021 | -29.13M |
| December 31, 2020 | -60.00M |
| December 31, 2019 | -75.60M |
| December 31, 2018 | -113.58M |
| Date | Value |
|---|---|
| December 31, 2017 | -291.96M |
| December 31, 2016 | -276.01M |
| December 31, 2015 | -239.28M |
| December 31, 2014 | -141.96M |
| December 31, 2013 | -54.66M |
| December 31, 2012 | -74.35M |
| December 31, 2011 | -10.23M |
| December 31, 2010 | -0.016M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Anika Therapeutics, Inc. | -9.979M |
| Arcutis Biotherapeutics, Inc. | -16.14M |
| Olema Pharmaceuticals, Inc. | -162.45M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |